306 related articles for article (PubMed ID: 22781601)
1. [Co-expression of CD99/MIC2 and ALK in anaplastic large-cell lymphoma tissues and its significance].
Zhong L; Wei QZ; Huang XP; Ji TH; Li F; Wang ZQ; Li XZ; Liu JH; Zhao T
Zhonghua Xue Ye Xue Za Zhi; 2012 Mar; 33(3):173-6. PubMed ID: 22781601
[TBL] [Abstract][Full Text] [Related]
2. Frequent expression of CD99 in anaplastic large cell lymphoma: a clinicopathologic and immunohistochemical study of 160 cases.
Buxton D; Bacchi CE; Gualco G; Weiss LM; Zuppan CW; Rowsell EH; Huang Q; Wang J
Am J Clin Pathol; 2009 Apr; 131(4):574-9. PubMed ID: 19289593
[TBL] [Abstract][Full Text] [Related]
3. [Clinicopathologic features of 66 cases of anaplastic lymphoma kinase positive and negative systemic anaplastic large cell lymphoma: a comparative study].
Shi Y; Chen G; Zhou XG; Gong LP; Yu R; Zheng YY; Xie JL; Jin Y
Zhonghua Bing Li Xue Za Zhi; 2010 Apr; 39(4):235-9. PubMed ID: 20654121
[TBL] [Abstract][Full Text] [Related]
4. Story of survival in anaplastic large cell lymphoma - sometimes more than the anaplastic lymphoma kinase status: An evaluation of pathologic prognostic factors in 102 cases.
Agrawal K; Shet T; Sridhar E; Dhende S; Sengar M; Arora B; Laskar S; Gujral S; Menon H; Banavali S
Indian J Pathol Microbiol; 2017; 60(4):533-540. PubMed ID: 29323068
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance and therapeutic potential of the activation of anaplastic lymphoma kinase/protein kinase B/mammalian target of rapamycin signaling pathway in anaplastic large cell lymphoma.
Gao J; Yin M; Zhu Y; Gu L; Zhang Y; Li Q; Jia C; Ma Z
BMC Cancer; 2013 Oct; 13():471. PubMed ID: 24112608
[TBL] [Abstract][Full Text] [Related]
6. Immunoreactivity of CD99 in non-Hodgkin's lymphoma: unexpected frequent expression in ALK-positive anaplastic large cell lymphoma.
Sung CO; Ko YH; Park S; Kim K; Kim W
J Korean Med Sci; 2005 Dec; 20(6):952-6. PubMed ID: 16361803
[TBL] [Abstract][Full Text] [Related]
7. High intratumoral macrophage content is an adverse prognostic feature in anaplastic large cell lymphoma.
Pedersen MB; Danielsen AV; Hamilton-Dutoit SJ; Bendix K; Nørgaard P; Møller MB; Steiniche T; d'Amore F
Histopathology; 2014 Oct; 65(4):490-500. PubMed ID: 24592992
[TBL] [Abstract][Full Text] [Related]
8. Clinical and laboratory characteristics of systemic anaplastic large cell lymphoma in Chinese patients.
Wang YF; Yang YL; Gao ZF; Zhou CJ; Gregg X; Shi YF; Wang J; Yang XF; Ke XY
J Hematol Oncol; 2012 Jul; 5():38. PubMed ID: 22769020
[TBL] [Abstract][Full Text] [Related]
9. Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma: current and future perspectives in adult and paediatric disease.
Eyre TA; Khan D; Hall GW; Collins GP
Eur J Haematol; 2014 Dec; 93(6):455-68. PubMed ID: 24766435
[TBL] [Abstract][Full Text] [Related]
10. ALK expression plays different roles in anaplastic large-cell lymphomas and outcome of crizotinib use in relapsed/refractory ALK+ patients in a Chinese population.
Huang L; Zhang F; Zeng J; Guo H; Liu S; Wei X; Chen F; Jiang X; Liang Z; Liu Y; Li W
Ann Hematol; 2018 Jan; 97(1):149-159. PubMed ID: 29150811
[TBL] [Abstract][Full Text] [Related]
11. [Anaplastic lymphoma kinase gene abnormality and the expression of its fusion protein in primary systemic anaplastic large cell lymphoma].
Shi YF; Liu CL; Zhou CJ; Gong LP; Dong LN; Li M; Huang X; Gao ZF
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 40(4):380-6. PubMed ID: 18677384
[TBL] [Abstract][Full Text] [Related]
12. Anaplastic large cell lymphoma: a single institution experience from India.
Lakshmaiah KC; Guruprasad B; Shah A; Kavitha S; Abraham LJ; Govindbabu K; Aruna Kumari BS; Appaji L
J Cancer Res Ther; 2013; 9(4):649-52. PubMed ID: 24518711
[TBL] [Abstract][Full Text] [Related]
13. [Expression of anaplastic lymphoma kinase and survivin proteins in anaplastic large cell lymphoma and its significance].
Li JF; Li GD; Liu WP; Wang Y; Cheng JR; Chen Y; Yang H; Tang HL; Bai YQ; Lin DG; DU LH; Peng FX; Yang YH; Zhao C
Zhonghua Bing Li Xue Za Zhi; 2006 Apr; 35(4):213-7. PubMed ID: 16776978
[TBL] [Abstract][Full Text] [Related]
14. [Study on activation of AKT/mTOR pathway in anaplastic large cell lymphoma].
Li JF; Li GD; Gu L; Liu WP; Li FY; Liao DY; Ma ZG
Zhonghua Xue Ye Xue Za Zhi; 2008 Oct; 29(10):649-53. PubMed ID: 19176054
[TBL] [Abstract][Full Text] [Related]
15. Extra copies of ALK gene locus is a recurrent genetic aberration and favorable prognostic factor in both ALK-positive and ALK-negative anaplastic large cell lymphomas.
Yu R; Chen G; Zhou C; Gao Z; Shi Y; Shi Y; Zhou X; Xie J; Liu H; Gong L
Leuk Res; 2012 Sep; 36(9):1141-6. PubMed ID: 22726922
[TBL] [Abstract][Full Text] [Related]
16. Primary gastrointestinal anaplastic large cell lymphoma.
Lee YY; Takata K; Wang RC; Yang SF; Chuang SS
Pathology; 2017 Aug; 49(5):479-485. PubMed ID: 28693749
[TBL] [Abstract][Full Text] [Related]
17. [Expressions and clinical significance of GAS1, IL-1RAP and PRF1 in patients with ALK positive anaplastic large cell lymphoma].
Jiang Y; Cao D; Xu CG
Zhonghua Xue Ye Xue Za Zhi; 2018 Feb; 39(2):116-121. PubMed ID: 29562445
[No Abstract] [Full Text] [Related]
18. Clinical and prognostic differences between ALK-negative anaplastic large cell lymphoma and peripheral T cell lymphoma, not otherwise specified: a single institution experience.
Deng XW; Zhang XM; Wang WH; Wang SL; Jin J; Fang H; Ren H; Liu YP; He XH; Dong M; Song YW; Li YX
Ann Hematol; 2016 Aug; 95(8):1271-80. PubMed ID: 27209536
[TBL] [Abstract][Full Text] [Related]
19. p53 and β-Catenin Expression Predict Poorer Prognosis in Patients With Anaplastic Large-Cell Lymphoma.
Richardson AI; Yin CC; Cui W; Li N; Medeiros LJ; Li L; Zhang D
Clin Lymphoma Myeloma Leuk; 2019 Jul; 19(7):e385-e392. PubMed ID: 31078446
[TBL] [Abstract][Full Text] [Related]
20. ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination.
ten Berge RL; Oudejans JJ; Ossenkoppele GJ; Pulford K; Willemze R; Falini B; Chott A; Meijer CJ
J Clin Pathol; 2000 Jun; 53(6):445-50. PubMed ID: 10911802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]